Chemours has secured court injunctions against four companies infringing on its patents for hydrofluoroolefin (HFO) refrigerant blends during Chillventa 2026 in Germany. This legal action highlights Chemours' commitment to protecting its intellectual property, supporting innovation, and ensuring fair competition in the refrigerants industry. The company is also working globally with authorities and educating stakeholders about the importance of using genuine refrigerants. This move aims to safeguard Chemours' investments in advanced refrigerant technology and help customers meet evolving industry standards.
Chemours' legal actions to protect refrigerant intellectual property provide context for readers interested in the refrigerants industry. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 19, 2026 17:11 WIB: Out of 83 priced US stocks, 42 rose and 27 fell. Notable movers include ALM at USD 10.08 (+2.54%, typical hold time 4 days), USAR at USD 10.79 (+2.37%, typical hold time 2 days), and SSL at USD 16.00 (-2.08%, typical hold time 3 days).
The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personali...
Starlink Mobile, launched by VEON Ltd. across Ukraine, Kazakhstan, and Bangladesh, has connected over 11 million users in less than a year. The service enables existing 4G phones to access satellite connectivity where terrestrial signals are unavaila...
Medallion Financial Corp. announced it will repurchase $15 million in trust preferred securities from BIMIZCI Fund LLC at 73.66% of face value, costing about $11.05 million plus accrued distributions. This deal includes a five-year standstill agreeme...
Belite Bio, a clinical-stage drug developer focused on retinal diseases, has been approved to move its stock listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest tier on Nasdaq. This uplisting reflects the company's ...
Heineken N.V. has repurchased a total of 8,865,521 shares under the second tranche of its €1.5 billion share buyback program, spending €629.4 million as of October 16, 2026. This includes shares bought on the exchange and from Heineken Holding N.V. T...
